Magnetic Insight

Magnetic Insight has pioneered magnetic particle imaging (MPI), a new diagnostic and monitoring technology that transforms medical imaging. MPI provides unique information not available from current structural and metabolic imaging captured by CT, MRI, and nuclear medicine. MPI offers what no other modality can: the ability to directly monitor costly cell therapy cancer treatments to inform clinical decision making. Having started in the preclinical space by selling small animal products to leading universities worldwide, Magnetic Insight is now scaling up MPI technology for clinical use.

Join our team as we grow! Visit the Careers page for the latest employment opportunities at Magnetic Insight.

Interested in keeping up with everything MPI? Check out the News page for the latest happenings in the field.

For all other inquiries, contact us here.

Executive Leadership

Patrick Goodwill, PhD

Co-founder / CTO / Interim CEO

Patrick Goodwill, PhD

Dr. Goodwill has spent the last 9 years leading the development team in Magnetic Particle Imaging at UC Berkeley. In his role, he has designed and built five prototype MPI scanners, and developed the x-space reconstruction systems theory that enables quantitative, high-quality MPI images.  Dr. Goodwill has a PhD in Bioengineering from UC Berkeley, and a  B.S. and M.S. in Electrical Engineering from Stanford University. Prior to UC Berkeley, Dr. Goodwill designed microprocessors at Intel Corporation.

Co-founder / CTO / CEO

John Carl

COO

John Carl

John Carl has 20 years of experience in developing life science tools. His broad experience includes leadership in operations, manufacturing, product development, and quality. He previously spent nearly 11 years at ProteinSimple developing and commercializing proteomics analysis systems, where he held director level roles in quality management, reagents manufacturing, and instrument manufacturing. More recently, he was the director of product development at Xcell Biosciences, where he led the development and manufacturing of next generation cell culture instrumentation. He holds a B.S. in Mechanical Engineering for UC Berkeley.

COO

Hans Layman, PhD

COO

Hans Layman, PhD

Dr. Hans Layman received his Ph.D. in Biomedical Engineering from the University of Miami in 2010 and has spent the last 12+ years in Translational Research and Development in oncology and infectious diseases. His expertise spans pre-clinical IND-enabling activities through late-stage clinical development (Phase 3 and beyond) for numerous modalities including small and large molecule, and novel biologics. He is an expert at molecular and immunological assay development and validation, translational sciences, and biomarker discovery.

Executive Director, Translational Research and Development

Board of Directors

Patrick Goodwill, PhD

Co-founder / CTO / CEO

Patrick Goodwill, PhD

Dr. Goodwill has spent the last 9 years leading the development team in Magnetic Particle Imaging at UC Berkeley. In his role, he has designed and built five prototype MPI scanners, and developed the x-space reconstruction systems theory that enables quantitative, high-quality MPI images.  Dr. Goodwill has a PhD in Bioengineering from UC Berkeley, and a  B.S. and M.S. in Electrical Engineering from Stanford University. Prior to UC Berkeley, Dr. Goodwill designed microprocessors at Intel Corporation.

Co-founder / CTO / CEO

David Allison

Partner at 5AM Ventures

David Allison

David Allison, Partner at 5AM Ventures with a PhD in Biomedical Engineering from Rice University has lead numerous HealthTech investments to success in the last 14 years.

Partner at 5AM Ventures

David Goldman

Celesta

David Goldman

Celesta

Joe Victor

CEO of Rarecyte

Joe Victor

Joe Victor, CEO of Rarecyte and serial entrepreneur is on his 3rd company breaking the mold in various areas of life science solutions. He is a seasoned veteran in growing startups into organizations with $100M in revenue.

CEO of Rarecyte

Anna Christensen, PhD

Co-founder

Anna Christensen, PhD

Dr Christensen has spent the last 16 years commercializing platform technologies in imaging and diagnostics. Most recently, she led the in vivo imaging business for PerkinElmer Inc and Caliper Life Sciences as the global business leader.  Prior to Caliper Life Sciences, she held senior management positions at DiscoverX and Molecular Devices. In addition to her commercial experience, she holds advanced degrees in cell biology and neurobiology from UC San Diego and Copenhagen University.

Co-founder

Nicholas Brathwaite

Celesta

Weijia (Victor) Wang

Celesta

The Advisors

Steven Conolly, PhD

Co-founder, MPI Professor at UC Berkeley

Steven Conolly, PhD

Prof. Conolly is a the Montford Cook Professor of Bioengineering, Electrical Engineering, and Computer Science at the University of California Berkeley. He received his Ph.D. in Electrical Engineering from Stanford University, where he developed new types of MRI scanners for over twenty years. At Berkeley he has applied his knowledge of building new imaging systems to MPI. He has a history of innovation, and for his many inventions, he was named one of only 24 people named a Stanford Outstanding Inventor.

Co-founder, Professor, UC Berkeley

Max Wintermark MD

Medical Advisor, Chief Neuroradiology Stanford

Max Wintermark MD

Dr. Wintermark is currently a Professor of Radiology and the Chief of Neuroradiology at the Stanford University. His specific interest and expertise is in stroke, traumatic brain injury, epilepsy, movement disorders and psychiatric disorders. He chairs on the research committees for the American Society of Neuroradiology (ASNR), American Society of Functional Neuroradiology (ASFNR) and the imaging working group of the NINDS-funded stroke clinical trial network (StrokeNET).

Medical Advisor, Chief of Neuroradiology, Stanford

Mike Harsh

Commercial Advisor, CTO GE Healthcare

Mike Harsh

Mr. Michael (Mike) Harsh is co-founder of Terapede Systems with over 36 years’ experience in healthcare technology, focused on diagnostic imaging. He served as Vice President and Chief Technology Officer for GE Healthcare, a $17 billion division of General Electric. As the Global Technology Leader of Imaging Technologies at GE Global Research, he led the research for X-Ray, CT, MRI, Ultrasound, Nuclear Medicine, PET and Optical Imaging, and the research associated with computer visualization/image analysis and superconducting systems. Mike was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, for his significant contributions to the medical and biological engineering field. Additionally, Mike holds numerous U.S. patents in the field of Medical Imaging and Instrumentation. Mike received a bachelor’s degree in Electrical Engineering from Marquette University, Milwaukee, Wisconsin, and he is a member of the University of Wisconsin Madison Industrial Advisory Board to the College of Engineering.

Commercial Advisor- Former, CTO GE Healthcare